نتایج جستجو برای: first complete remission

تعداد نتایج: 1748659  

Journal: :Dermatology 2016
Mosab T Mohanna Günther F L Hofbauer

Ingenol mebutate (IM) is a topical pharmacotherapy approved in Switzerland since 2012 for treating non-hypertrophic, non-hyperkeratotic actinic keratosis (AK). We report 2 cases with off-label use of IM. The first case of bowenoid AK was treated with 150 μg IM for 3 consecutive days with an almost complete clinical remission of the lesion. The second case of Bowen's disease was treated with 500...

Journal: :Neurology - Neuroimmunology Neuroinflammation 2015

Journal: :Annals of the Rheumatic Diseases 1982

Journal: :Journal of Korean Medical Science 1993
S. W. Kim K. H. Lee J. S. Lee C. Suh M. J. Ahn H. S. Chi S. H. Kim

Acute promyelocytic leukemia (APL) is a distinct subset of acute myeloid leukemia (AML) and is distinguished from other subsets of AML by its distinctive morphology, specific chromosomal abnormality, associated consumptive coagulopathy, and response to treatment. Interestingly, patients with APL frequently enter complete remission without undergoing a characteristic period of bone marrow hypopl...

Journal: :Haematologica 2015
Daisuke Araki Megan Othus Roland B Walter Vicky Sandhu Brenda M Sandmaier Pamela S Becker Frederick R Appelbaum Elihu H Estey

Several studies have shown that allogeneic hematopoietic cell transplantation (HCT) in first complete remission (CR1) of AML reduces the risk of relapse and improves relapse-free survival in intermediateand poor-risk AML. Benefits in (overall) survival are less obvious. One possible explanation is that following the occurrence of relapse, previous receipt of allogeneic HCT in CR1 is associated ...

Journal: :Haematology and blood transfusion 1985
P Jacobs

A total of 232 previously untreated adults with acute nonlymphoblastic leukaemia were consecutively entered into four successive studies. In the first, complete remission rates and survival were inferior to a group treated on the same regimen in London, suggesting population differences, possibly on the basis of late referral and poor nutritional status. In the second study the addition of the ...

2008
Ardeshir Ghavamzadeh Kamran Alimoghaddam Hamidolah Ghafari Shahrbano Rostami Yousef Mortazavi Mohamad Jahani Roholah Hosseini Asadolah Mossavi Massoud Iravani Babak Bahar Mehrangiz Totonchi Ali Khodabandeh Nasser Aghdami

Introduction: Arsenic Trioxide is effective and approved for treatment of relapsed or refractory APL cases to ATRA but its effects in new cases of APL is not clear and needs long term follow up to disclose the role of this drug in treatment of APL in combination with chemotherapy/ATRA or alone. Material and methods: we studied 111cases of APL (94 new case and 17 relapsed) diagnosed by morpholog...

Abedini Robabe Chams-Davatchi Cheyda Daneshpazhooh Maryam Esmaili Nafiseh Ghiasi Maryam Mortazavi Hossein Roghani Iman

Background: Pemphigus vulgaris (PV) is an autoimmune bullous disorder that is fatal if left untreated. High dose systemic corticosteroids are the basis of therapy. The addition of immunosuppressive agents has improved the disease outcome and reduced the required corticosteroid dose and related toxicity. Mycophenolate mofetil is increasingly used as a steroid-sparing agent in immunotherapy of PV...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید